| scholarly article | Q13442814 |
| P50 | author | Ralph Weissleder | Q7288259 |
| Tyler Jacks | Q7860044 | ||
| David Kirsch | Q46190448 | ||
| Rebecca D Dodd | Q57612264 | ||
| Sam S Yoon | Q88957109 | ||
| Umar Mahmood | Q104112476 | ||
| G Petur Nielsen | Q117232775 | ||
| Lars Stangenberg | Q117258470 | ||
| P2093 | author name string | Kwan-Hyuck Baek | |
| Jonathan M Dreyfuss | |||
| Peter J Park | |||
| Yoon-Jin Lee | |||
| Sandra Ryeom | |||
| Carolyn J Fisher | |||
| Courtney Rothrock | |||
| Peter R Waterman | |||
| P2860 | cites work | Therapeutic nanoparticles for drug delivery in cancer | Q28271255 |
| Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. | Q30310994 | ||
| Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx: possible implications of molecular biology and compartmentation. | Q34217087 | ||
| Harnessing preclinical mouse models to inform human clinical cancer trials. | Q34498952 | ||
| Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. | Q35149539 | ||
| Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations | Q36056383 | ||
| DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents | Q36702766 | ||
| Tomographic fluorescence imaging of tumor vascular volume in mice | Q36746093 | ||
| Molecular basis for sunitinib efficacy and future clinical development | Q36906667 | ||
| Radiation therapy plus angiogenesis inhibition with bevacizumab: rationale and initial experience | Q37161279 | ||
| Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer | Q37219981 | ||
| Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. | Q38324116 | ||
| SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation | Q39976736 | ||
| TORC1 is essential for NF1-associated malignancies | Q40029605 | ||
| Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression. | Q40335504 | ||
| Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. | Q42166673 | ||
| In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. | Q44285254 | ||
| SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models | Q44521076 | ||
| Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth | Q46613131 | ||
| Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter | Q48123453 | ||
| A spatially and temporally restricted mouse model of soft tissue sarcoma. | Q50943688 | ||
| Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy | Q74067262 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 1207-1216 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma | |
| P478 | volume | 74 |
| Q91689005 | A Feedback Loop between Hypoxia and Matrix Stress Relaxation Increases Oxygen-Axis Migration and Metastasis in Sarcoma |
| Q34098113 | Animal models of soft-tissue sarcoma. |
| Q38847330 | Assessment of tumor response to radiation and vascular targeting therapy in mice using quantitative ultrasound spectroscopy |
| Q43179458 | Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy |
| Q35776891 | CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression |
| Q53464347 | Combined radiation therapy and sunitinib for preoperative treatment of soft tissue sarcoma. |
| Q36965629 | Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03). |
| Q88566946 | Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology |
| Q26800587 | Combining radiotherapy with sunitinib: lessons (to be) learned |
| Q34396047 | Combining targeted agents with modern radiotherapy in soft tissue sarcomas |
| Q44760028 | Dose-dependent response of tumor vasculature to radiation therapy in combination with Sunitinib depicted by three-dimensional high-frequency power Doppler ultrasound |
| Q47135426 | Early Assessment of Tumor Response to Radiation Therapy using High-Resolution Quantitative Microvascular Ultrasound Imaging |
| Q54457952 | Gastro-pleuro-pericardial fistula following combined radiation and chemotherapy for lung metastases from renal cell carcinoma: report of a case. |
| Q36286658 | Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas |
| Q37294778 | Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. |
| Q27321370 | Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts |
| Q36027155 | Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature |
| Q41693158 | Methods to generate genetically engineered mouse models of soft tissue sarcoma. |
| Q37333673 | Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors. |
| Q47903507 | O2-controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo |
| Q38496656 | Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α. |
| Q37190323 | Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma |
| Q37094908 | Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021. |
| Q26822744 | Preclinical models in radiation oncology |
| Q36974779 | Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs |
| Q37403232 | Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents. |
| Q37742014 | Targeted therapy for soft tissue sarcomas in adolescents and young adults |
| Q55111807 | The Possible Mechanisms of HSV-TK/Hyperthermia Combined with 131I-antiAFPMcAb-GCV Nanospheres to Treat Hepatoma. |
| Q38252537 | The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets. |
| Q51435849 | Tyrosine Kinase Receptor Expression in Canine Liposarcoma. |
| Q42147601 | Using genetically engineered mice for radiation research |
| Q38008461 | Vascular strategies for enhancing tumour response to radiation therapy |
Search more.